aromasil has been researched along with Lung Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gulde, A; Hasanov, E; Krucke, GW; Krug, K | 1 |
| Chlebowski, RT; Lin, EM; Pan, K | 1 |
| Cheng, Y; Cristofanilli, M; Cui, S; Feng, J; Gao, J; Geng, C; Gu, K; Hu, X; Jiang, Z; Li, W; Liu, T; Lu, X; Ning, Z; Ouyang, Q; Ouyang, T; Pan, Y; Sun, T; Sun, Y; Tong, Z; Wang, H; Wang, S; Wang, X; Yin, Y; Zhang, Q | 1 |
| Arena, FP; Baselga, J; Burris, HA; Cahana, A; Campone, M; Erdkamp, F; Feng, W; Gnant, M; Harb, WA; Hortobagyi, GN; Lebwohl, D; Melichar, B; Noguchi, S; Petrakova, K; Piccart, M; Pistilli, B; Pritchard, KI; Rugo, HS; Taran, T; Yardley, DA | 1 |
| Cordone, I; Cortese, G; Galati, R; Germoni, S; Masi, S; Morosetti, C; Nuvoli, B; Santoro, R | 1 |
| Athanassiou, G; Giannopoulou, E; Kalofonos, HP; Kalofonou, M; Koutras, A; Kritikou, I; Metsiou, D; Papachristou, DJ; Siatis, KE | 1 |
| Lanuti, M; Lerwill, MF; Moy, B; Rafferty, EA; Specht, MC | 1 |
| Bachelot, T; Crétin, J; Debled, M; Delozier, T; Falandry, C; Freyer, G; Mauriac, L; Mille, D; Pujade-Lauraine, E; Romestaing, P; You, B | 1 |
| Bines, J; Mauriac, L; Romieu, G | 1 |
| Abreu, P; Cameron, DA; Campos, SM; Guastalla, JP; Subar, M; Winer, EP | 1 |
| Antonacopoulou, A; Evans, TR; Giannopoulou, E; Kalofonos, H; Koutras, A; Kritikou, I; Papavassiliou, AG | 1 |
| Cartei, G; Endri, M; Fassina, A; Serino, FS; Zustovich, F | 1 |
| Aogi, K; Hara, F; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
| Aoki, T; Kaise, H; Katsumata, K; Kusama, M; Nakayama, S; Ota, D | 1 |
| Giordano, SH; Hortobagyi, GN | 1 |
| Beresford, MJ; Chin, YS; Makris, A; Ravichandran, D | 1 |
5 trial(s) available for aromasil and Lung Neoplasms
| Article | Year |
|---|---|
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Aminopyridines; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Breast Neoplasms; Double-Blind Method; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Salvage Therapy; Survival Rate; Treatment Outcome | 2019 |
Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Everolimus; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Sirolimus; Treatment Outcome | 2013 |
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Celecoxib; Chemotherapy, Adjuvant; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Placebos; Postmenopause; Prognosis; Pyrazoles; Soft Tissue Neoplasms; Sulfonamides; Survival Rate; Treatment Outcome | 2009 |
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Estradiol; Female; Fulvestrant; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Viscera | 2009 |
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Brain Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nitriles; Pilot Projects; Postmenopause; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles | 2009 |
11 other study(ies) available for aromasil and Lung Neoplasms
| Article | Year |
|---|---|
Everolimus-induced pneumonitis: A diagnostic challenge.
Topics: Androstadienes; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ductal, Breast; Computed Tomography Angiography; Cough; Diagnosis, Differential; Dyspnea; Everolimus; Female; Glucocorticoids; Humans; Lung Neoplasms; Methylprednisolone; Middle Aged; Pneumonia; Pneumonia, Bacterial; Pulmonary Embolism; Pulse Therapy, Drug; Radiography, Thoracic; Tomography, X-Ray Computed | 2020 |
Emerging combination endocrine therapies for advanced breast cancer.
Topics: Adult; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Everolimus; Female; Humans; Lung Neoplasms; Receptor, ErbB-2; Receptors, Estrogen | 2018 |
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
Topics: Androstadienes; Animals; Aromatase Inhibitors; Cell Proliferation; Cisplatin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Xenograft Model Antitumor Assays | 2014 |
The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration.
Topics: Actins; Androstadienes; Apoptosis; Aromatase; Aromatase Inhibitors; Biomechanical Phenomena; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Shape; Cytoskeleton; Elastic Modulus; Humans; Lung Neoplasms; Neoplasm Invasiveness; Rheology; Tubulin; Vimentin | 2015 |
Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Class I Phosphatidylinositol 3-Kinases; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Mastectomy, Segmental; Mutation; Nitriles; Phosphatidylinositol 3-Kinases; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Triazoles | 2015 |
Antiproliferative effect of exemestane in lung cancer cells.
Topics: Androstadienes; Apoptosis; Aromatase; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Phosphorylation; Protein Transport; RNA, Messenger; Testosterone | 2009 |
Differential diagnosis of lung nodules: breast cancer metastases and lung tuberculosis.
Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Estrogens; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms, Hormone-Dependent; Progesterone; Recurrence; Tamoxifen; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2010 |
Examination of the use of Exemestane in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Tamoxifen | 2011 |
[A case of aged advanced breast cancer with multiple lung and pleural metastases responding to exemestane monotherapy].
Topics: Aged; Androstadienes; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Female; Humans; Lung Neoplasms; Mucin-1; Pleural Neoplasms | 2004 |
Leuprolide acetate plus aromatase inhibition for male breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Humans; Letrozole; Leuprolide; Lung Neoplasms; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Middle Aged; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Triazoles | 2006 |
Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Postmenopause; Retrospective Studies; Soft Tissue Neoplasms | 2007 |